ArticleCancer medicine2019

The clinical study on treatment of CD19-directed chimeric antigen receptor-modified T cells in a case of refractory Richter syndrome.

Leiming Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.